Emulate CEO and leadership

Global Healthcare and Life Science Executive with a history of exceeding goals and driving results. Transformation Expert who thrives in complex situations, leading organizational growth and change management by designing and implementing continuous improvement plans. Experience ranges from Fortune 100 companies to entrepreneurial start-ups.

• 25+ years of successful international businesses leadership across diverse sectors, including biotechnology, medical imaging, analytical instruments and in vitro diagnostics.

• Deep track record leading successful international businesses and teams across diverse sectors, including biotechnology, medical imaging, analytical instruments and in-vitro diagnostics; experience ranging from large Fortune 100 companies to founding, growing and successfully exiting a small entrepreneurial start-up.

• Brings extensive M&A leadership expertise, both domestic and international, with a strong emphasis on China.

• Trusted advisor to and partner of senior management, valued for decisive leadership, sound business judgment and strategic vision.

• Collaborative, creative problem-solver who creates an environment that challenges the status quo, rewards results and continuous improvement, and builds trust through respect, open communication and consistently delivering on commitments.

• Respected builder of successful teams and relationships who ensures the right people are in the right positions, empowers them to grow and celebrates their successes.

• Adept corporate and financial strategic planner who develops and leads mid- and large-range plans in high-growth, mature and turnaround environments.

• Profit generator who consistently exceeded revenue and profit targets while outperforming competition and industry markets.

• Strong, transparent, honest communicator and listener who clearly simplifies and explains complicated information to a wide variety of constituents.

Daniel Levner is Emulate’s Chief Technology Officer. Prior to joining Emulate’s founding team, he was a Senior Staff Scientist with the Wyss Institute for Biologically Inspired Engineering at Harvard University, where he led the advanced engineering team responsible for developing Emulate’s Organs-on-Chips platform. Levner played a key leadership role in managing the multidisciplinary Organs-on-Chips team by formulating innovative approaches for fostering close collaboration and in-depth exchange between biologists and engineers. Levner brings this tight integration of disciplines to Emulate, where it is a defining part of the company’s culture. Prior to directing the Organs-on-Chips program, Levner worked with world-renowned Harvard geneticist Prof. George M. Church in programs related to medical diagnostics, DNA/RNA sequencing tools, and multiplexed analysis techniques. As an entrepreneur, Levner co-founded a medical diagnostics startup company, and earlier in his career, an optical telecommunications startup company. Levner received his Ph.D. in electrical engineering from Stanford University as well as an M.S. in aeronautics and astronautics, also from Stanford. He has authored numerous publications and more than 20 issued and pending patents.

Geraldine A. Hamilton is the President and Chief Scientific Officer of Emulate. Prior to joining Emulate’s founding team, she served as Lead Senior Staff Scientist with the Wyss Institute for Biologically Inspired Engineering at Harvard University. At the Wyss Institute, Hamilton lead the Organs-on-Chips program and managed the multidisciplinary team responsible for developing, translating and commercializing the Organs-on-Chips technology. Hamilton’s career spans industry, academia and the start-up world. Prior to her tenure at Harvard University, Hamilton spent more than 11 years in the pharmaceutical industry in leadership roles managing drug discovery teams. Her research achievements helped advance the development and application of human relevant in vitro models for drug discovery. Hamilton was a founding scientist and VP of Scientific Operations for CellzDirect, a start-up biotech company that specialized in providing cell products to the pharmaceutical industry for safety testing. Hamilton was responsible for the successful translation of CellzDirect’s technology from academia to broad use and acceptance across the industry. Hamilton received her Ph.D. in cell biology/toxicology from the University of Hertfordshire (England) in conjunction with GlaxoSmithkline, followed by a post-doctoral research fellowship at the University of North Carolina. She has authored more than 40 publications and numerous patents.

Daniel Levner is Emulate’s Chief Technology Officer. Prior to joining Emulate’s founding team, he was a Senior Staff Scientist with the Wyss Institute for Biologically Inspired Engineering at Harvard University, where he led the advanced engineering team responsible for developing Emulate’s Organs-on-Chips platform. Levner played a key leadership role in managing the multidisciplinary Organs-on-Chips team by formulating innovative approaches for fostering close collaboration and in-depth exchange between biologists and engineers. Levner brings this tight integration of disciplines to Emulate, where it is a defining part of the company’s culture. Prior to directing the Organs-on-Chips program, Levner worked with world-renowned Harvard geneticist Prof. George M. Church in programs related to medical diagnostics, DNA/RNA sequencing tools, and multiplexed analysis techniques. As an entrepreneur, Levner co-founded a medical diagnostics startup company, and earlier in his career, an optical telecommunications startup company. Levner received his Ph.D. in electrical engineering from Stanford University as well as an M.S. in aeronautics and astronautics, also from Stanford. He has authored numerous publications and more than 20 issued and pending patents.

Geraldine A. Hamilton is the President and Chief Scientific Officer of Emulate. Prior to joining Emulate’s founding team, she served as Lead Senior Staff Scientist with the Wyss Institute for Biologically Inspired Engineering at Harvard University. At the Wyss Institute, Hamilton lead the Organs-on-Chips program and managed the multidisciplinary team responsible for developing, translating and commercializing the Organs-on-Chips technology. Hamilton’s career spans industry, academia and the start-up world. Prior to her tenure at Harvard University, Hamilton spent more than 11 years in the pharmaceutical industry in leadership roles managing drug discovery teams. Her research achievements helped advance the development and application of human relevant in vitro models for drug discovery. Hamilton was a founding scientist and VP of Scientific Operations for CellzDirect, a start-up biotech company that specialized in providing cell products to the pharmaceutical industry for safety testing. Hamilton was responsible for the successful translation of CellzDirect’s technology from academia to broad use and acceptance across the industry. Hamilton received her Ph.D. in cell biology/toxicology from the University of Hertfordshire (England) in conjunction with GlaxoSmithkline, followed by a post-doctoral research fellowship at the University of North Carolina. She has authored more than 40 publications and numerous patents.

Global Healthcare and Life Science Executive with a history of exceeding goals and driving results. Transformation Expert who thrives in complex situations, leading organizational growth and change management by designing and implementing continuous improvement plans. Experience ranges from Fortune 100 companies to entrepreneurial start-ups.

• 25+ years of successful international businesses leadership across diverse sectors, including biotechnology, medical imaging, analytical instruments and in vitro diagnostics.

• Deep track record leading successful international businesses and teams across diverse sectors, including biotechnology, medical imaging, analytical instruments and in-vitro diagnostics; experience ranging from large Fortune 100 companies to founding, growing and successfully exiting a small entrepreneurial start-up.

• Brings extensive M&A leadership expertise, both domestic and international, with a strong emphasis on China.

• Trusted advisor to and partner of senior management, valued for decisive leadership, sound business judgment and strategic vision.

• Collaborative, creative problem-solver who creates an environment that challenges the status quo, rewards results and continuous improvement, and builds trust through respect, open communication and consistently delivering on commitments.

• Respected builder of successful teams and relationships who ensures the right people are in the right positions, empowers them to grow and celebrates their successes.

• Adept corporate and financial strategic planner who develops and leads mid- and large-range plans in high-growth, mature and turnaround environments.

• Profit generator who consistently exceeded revenue and profit targets while outperforming competition and industry markets.

• Strong, transparent, honest communicator and listener who clearly simplifies and explains complicated information to a wide variety of constituents.

Daniel Levner is Emulate’s Chief Technology Officer. Prior to joining Emulate’s founding team, he was a Senior Staff Scientist with the Wyss Institute for Biologically Inspired Engineering at Harvard University, where he led the advanced engineering team responsible for developing Emulate’s Organs-on-Chips platform. Levner played a key leadership role in managing the multidisciplinary Organs-on-Chips team by formulating innovative approaches for fostering close collaboration and in-depth exchange between biologists and engineers. Levner brings this tight integration of disciplines to Emulate, where it is a defining part of the company’s culture. Prior to directing the Organs-on-Chips program, Levner worked with world-renowned Harvard geneticist Prof. George M. Church in programs related to medical diagnostics, DNA/RNA sequencing tools, and multiplexed analysis techniques. As an entrepreneur, Levner co-founded a medical diagnostics startup company, and earlier in his career, an optical telecommunications startup company. Levner received his Ph.D. in electrical engineering from Stanford University as well as an M.S. in aeronautics and astronautics, also from Stanford. He has authored numerous publications and more than 20 issued and pending patents.